5 5. Doolittle GC, Allen A. Practising oncology via telemedicine. J Telemed Telecare. 1997; 3:63–70.
6 6. Doolittle GC, Spaulding AO. Providing Access to Oncology Care for Rural Patients via Telemedicine. J Oncol Pract. 2006; 2:228230.
7 7. Doolittle GC, Spaulding AO, Williams AR. The decreasing cost of telemedicine and telehealth. Telemed J E Health. 2011; 17:671–675.
8 8. Sharma JJ, Gross G, Sharma P. Extending Oncology Clinical Services to Rural Areas of Texas Via Teleoncology. J Oncol Pract. 2012; 8:68.
9 9. Sabesan S, Roberts LJ, Aiken P, et al. Timely access to specialist medical oncology services closer to home for rural patients: experience from the Townsville Teleoncology Model. Aust J Rural Health. 2014; 22:156–159.
10 10. Thaker DA, Monypenny R, Olver I, Sabesan S. Cost savings from a telemedicine model of care in northern Queensland, Australia. Med J Aust. 2013; 199:414–417.
11 11. Sirintrapun SJ, Lopez AM. Telemedicine in Cancer Care. Am Soc Clin Oncol Educ Book. 2018; 38:540–545.
12 12. Reardon T. Research findings and strategies for assessing telemedicine costs. Telemed J E Health. 2005; 11:348–369.
13 13. Trout KE, Rampa S, Wilson FA, Stimpson JP. Legal Mapping Analysis of State Telehealth Reimbursement Policies. Telemed J E Health. 2017; 23:805–814.
14 14. Marcoux RM, Vogenberg FR. Telehealth: Applications From a Legal and Regulatory Perspective. P T. 2016; 41:567–570.
15 15. Utidjian L, Abramson E. Pediatric Telehealth: Opportunities and Challenges. Pediatr Clin North Am. 2016; 63:367–378.
16 16. Kruse CS, Krowski N, Rodriguez B, et al. Telehealth and patient satisfaction: a systematic review and narrative analysis. BMJ Open. 2017; 7:e016242.
17 17. National Quality Forum Final Report. Creating a Framework to Support Measure Development for Telehealth. 2017. Available from: https://www.qualityforum.org/Publications/2017/08/Creating_a_Framework_to_Support_Measure_Development_for_Telehealth.aspx (accessed 1 October 2017).
18 18. Gilman M, Stensland J. Telehealth and Medicare: payment policy, current use, and prospects for growth. Medicare Medicaid Res Rev. 2013; 3(4):mmrr.003.04.a04.
19 19. Bertucci F, Le Corroller‐Soriano AG, Monneur‐Miramon A, et al. Outpatient Cancer Care Delivery in the Context of E‐Oncology: A French Perspective on “Cancer outside the Hospital Walls”. Cancers (Basel). 2019; 11(2):219.
20 20. Charlton M, Schlichting J, Chioreso C, et al. Challenges of Rural Cancer Care in the United States. Oncology (Williston Park). 2015; 29:633–640.
21 21. Hashmi S, Carpenter P, Khera N, et al. Lost in transition: the essential need for long‐term follow‐up clinic for blood and marrow transplantation survivors. Biol Blood Marrow Transplant. 2015; 21:225–232.
22 22. Dyer G, Gilroy N, Brown L, et al. What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long‐Term Health in Sydney, Australia. Biol Blood Marrow Transplant. 2016; 22:731–743.
23 23. Cox A, Lucas G, Marcu A, et al. Cancer Survivors' Experience With Telehealth: A Systematic Review and Thematic Synthesis. J Med Internet Res. 2017; 19:e11.
24 24. Adler‐Milstein J, Kvedar J, Bates DW. Telehealth among US hospitals: several factors, including state reimbursement and licensure policies, influence adoption. Health Aff (Millwood). 2014; 33:207–215.
25 25. Mars M, Morris C, Scott RE. Selfie Telemedicine ‐ What Are the Legal and Regulatory Issues? Stud Health Technol Inform. 2018; 254:53–62.
26 26. Brous E. Legal Considerations in Telehealth and Telemedicine. Am J Nurs. 2016; 116:64–67.
27 27. Waller M, Stotler C. Telemedicine: a Primer. Curr Allergy Asthma Rep. 2018; 18:54.
28 28. Chaet D, Clearfield R, Sabin JE, et al. Ethical practice in Telehealth and Telemedicine. J Gen Intern Med. 2017; 32:1136–1140.
29 29. Krynski L, Goldfarb G, Maglio I. Technology‐mediated communication with patients: WhatsApp Messenger, e‐mail, patient portals. A challenge for pediatricians in the digital era. Arch Argent Pediatr. 2018; 116:e554–e559.
30 30. Stevenson P, Finnane AR, Soyer HP. Teledermatology and clinical photography: safeguarding patient privacy and mitigating medico‐legal risk. Med J Aust. 2016; 204:198–200e1.
31 31. State Telehealth Laws and Reimbursement Policies Report. 2019. Available from: https://www.cchpca.org/telehealth‐policy/state‐telehealth‐laws‐and‐reimbursement‐policies‐report ().
32 32. Costello AG, Nugent BD, Conover N, et al. Shared Care of Childhood Cancer Survivors: A Telemedicine Feasibility Study. J Adolesc Young Adult Oncol. 2017; 6:535–541.
33 33. Hashmi SK, Lee SJ, Savani BN, et al. ASBMT Practice Guidelines Committee Survey on Long‐Term Follow‐Up Clinics for Hematopoietic Cell Transplant Survivors. Biol Blood Marrow Transplant. 2018; 24:1119–1124.
34 34. Jagasia M, Clifton C, Vaughan LA, et al. Impact of longitudinal long‐term transplant clinic (LTTC) on survival after allogeneic stem cell transplant (SCT). Biol Blood Marrow Transplant. 2008; 14(supp):107.
35 35. Ragon BK, Clifton C, Chen H, et al. Geographic distance is not associated with inferior outcome when using long‐term transplant clinic strategy. Biol Blood Marrow Transplant. 2014; 20:53–57.
36 36. Rao K, Darrington DL, Schumacher JJ, et al. Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence. Biol Blood Marrow Transplant. 2007; 13:1508–1514.
37 37. Abou‐Nassar KE, Kim HT, Blossom J, et al. The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012; 18:708–715.
38 38. Loberiza FR Jr, Lee SJ, Klein JP, et al. Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence. Biol Blood Marrow Transplant. 2010; 16:368375.
39 39. Mani S, Rybicki L, Carraway H, et al. Primary care physician preferences and perspectives on long‐term care of survivors of hematologic malignancies and hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016; 22(Suppl 3):S85–S86.
40 40. Majhail NS, Murphy E, Laud P, et al. Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors. Haematologica. 2019; 104:1084–1092.
41 41. Khera N, Gooley T, Flowers MED, et al. Association of Distance from Transplantation Center and Place of Residence on Outcomes after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016; 22:1319–1323.
42 42. Inamoto Y, Kim DD, Storer BE, et al. Application of CIBMTR risk score to NIH chronic GVHD at individual centers. Blood. 2014; 123:453–455.
43 43. Arora M, Hemmer MT, Ahn KW, et al. Center for International Blood and Marrow Transplant Research chronic graft‐versus‐host disease risk score predicts mortality in an independent validation cohort. Biol Blood Marrow Transplant. 2015; 21:640–645.
44 44. Powell RE, Henstenburg JM, Cooper G, et al. Patient Perceptions of Telehealth Primary Care Video Visits. Ann Fam Med. 2017; 15:225–229.
45 45. Wootton R. Twenty years of telemedicine in chronic disease management–an evidence synthesis. J Telemed Telecare. 2012; 18:211–220.
46 46. Ahrendt AD, Kattelmann KK, Rector TS, Maddox DA. The effectiveness of telemedicine for weight management in the MOVE! Program. J Rural Health. 2014; 30:113–119.
47 47. Myhill K. Telepsychiatry in